Shire Targets Mylan In Latest Suit Over Generic Vyvanse
By Leigh Kamping-Carder · July 15, 2011, 5:37 PM EDT
Shire PLC sued Mylan Inc. on Thursday in New York over a planned generic version of the attention deficit hyperactivity disorder treatment Vyvanse, marking the company's latest effort to protect the...
To view the full article, register now.